Epizyme Inc. (EPZM) Drops 5.56% on January 04

Equities Staff |

Epizyme Inc. (EPZM) was one of the Russell 2000's biggest losers for Monday January 04 as the stock slid 5.56% to $15.13, a loss of $-0.89 per share. Starting at an opening price of $15.66 a share, the stock traded between $15.07 and $16.01 over the course of the trading day. Volume was 145,750 shares over 1,830 trades, against an average daily volume of 453,839 shares and a total float of 41.7 million.

The losses send Epizyme Inc. down to a market cap of $630.97 million. In the last year, Epizyme Inc. has traded between $28.48 and $11.26, and its 50-day SMA is currently $15.24 and 200-day SMA is $18.14.

Epizyme Inc is a clinical stage biopharmaceutical company. The Company discovers, develops and commercializes novel epigenetic therapies for cancer patients.

Epizyme Inc. is based out of Cambridge, MA and has some 86 employees. Its CEO is Robert Bazemore.

For a complete fundamental analysis analysis of Epizyme Inc., check out Equities.com’s Stock Valuation Analysis report for EPZM. To see the latest independent stock recommendations from Equities.com’s analysts, visit our Research section.

The Russell 2000 is one of the leading indices tracking small-cap companies in the United States. It's maintained by Russell Investments, an industry leader in creating and maintaining indices, and consists of the smallest 2000 stocks from the broader Russell 3000 index.

Russell's indices differ from traditional indices like the Dow Jones Industrial Average (DJIA) or S&P 500, whose members are selected by committee, because they base membership entirely on an objective, rules based methodology. The 3,000 largest companies by market cap make up the Russell 3000, with the 2,000 smaller companies making up the Russell 2000. It's a simple approach that gives a broad, unbiased look at the small-cap market as a whole.

For more news on the financial markets, go to Equities.com. Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer


Emerging Growth

IGEN Networks Corp.

iGen Networks Corp is engaged in investing in and managing for growth private high-tech companies that offer products and services in the domains of wireless broadband, software as a service,…

Private Markets


A peer-to-Peer authentic photo marketplace disrupting the $10B commercial photography industry.


Trustify provides trust and safety in both the digital and physical worlds through our vast network of on-demand Private Investigators.By removing the large retainers and high hourly rates that traditional…